Jardiance

empagliflozin · Boehringer Ingelheim and Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

85 regulatory and trial events tracked for Jardiance, covering 2014-06-18 to 2026-08-10. Get the full timeline:

Most recent: Clinical Trial Results: Jardiance® Post Marketing Surveillance (PMS) in Korean Patients With Chronic Heart Failure